These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 18394087

  • 1. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J, Kerdel F.
    Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
    [Abstract] [Full Text] [Related]

  • 2. [Psoriasis in the era of biologics].
    Torres T, Velho GC, Sanches M, Selores M.
    Acta Med Port; 2010; 23(3):493-8. PubMed ID: 20654269
    [Abstract] [Full Text] [Related]

  • 3. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
    Alwawi EA, Krulig E, Gordon KB.
    Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
    [Abstract] [Full Text] [Related]

  • 4. [The biological treatments for moderate to severe plaque psoriasis].
    Thielen AM, Marazza G.
    Rev Med Suisse; 2008 Apr 30; 4(155):1089-90, 1092-4. PubMed ID: 18610721
    [Abstract] [Full Text] [Related]

  • 5. Identifying the biologic closest to the ideal to treat chronic plaque psoriasis in different clinical scenarios: using a pilot multi-attribute decision model as a decision-support aid.
    Guibal F, Iversen L, Puig L, Strohal R, Williams P.
    Curr Med Res Opin; 2009 Dec 30; 25(12):2835-43. PubMed ID: 19916728
    [Abstract] [Full Text] [Related]

  • 6. The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics.
    Levine D, Strober BE.
    Semin Cutan Med Surg; 2010 Mar 30; 29(1):28-34. PubMed ID: 20430305
    [Abstract] [Full Text] [Related]

  • 7. Biological agents in the treatment of psoriasis.
    Tzu J, Krulig E, Cardenas V, Kerdel FA.
    G Ital Dermatol Venereol; 2008 Oct 30; 143(5):315-27. PubMed ID: 18833073
    [Abstract] [Full Text] [Related]

  • 8. Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents.
    Sobell JM, Kalb RE, Weinberg JM.
    J Drugs Dermatol; 2009 Feb 30; 8(2):147-54. PubMed ID: 19213230
    [Abstract] [Full Text] [Related]

  • 9. Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data.
    Rustin MH.
    Br J Dermatol; 2012 Nov 30; 167 Suppl 3():3-11. PubMed ID: 23082810
    [Abstract] [Full Text] [Related]

  • 10. Use of biologic agents in pediatric psoriasis.
    Marji JS, Marcus R, Moennich J, Mackay-Wiggan J.
    J Drugs Dermatol; 2010 Aug 30; 9(8):975-86. PubMed ID: 20684148
    [Abstract] [Full Text] [Related]

  • 11. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
    van de Kerkhof PC, Mrowietz U, Segaert S, Kragballe K.
    Br J Dermatol; 2007 Apr 30; 156(4):771-2. PubMed ID: 17263798
    [No Abstract] [Full Text] [Related]

  • 12. Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics.
    Sator P, Richter L, Saxinger W, Vasiljevic M, Stingl G.
    J Eur Acad Dermatol Venereol; 2015 Sep 30; 29(9):1742-9. PubMed ID: 25665143
    [Abstract] [Full Text] [Related]

  • 13. The status of biologic therapies in the treatment of moderate to severe psoriasis.
    Menter A.
    Cutis; 2009 Oct 30; 84(4 Suppl):14-24. PubMed ID: 19916298
    [Abstract] [Full Text] [Related]

  • 14. The role of biologics and other systemic agents in the treatment of pediatric psoriasis.
    Wright NA, Piggott CD, Eichenfield LF.
    Semin Cutan Med Surg; 2010 Mar 30; 29(1):20-7. PubMed ID: 20430304
    [No Abstract] [Full Text] [Related]

  • 15. Long-term data in the treatment of psoriasis.
    Thaçi D.
    Br J Dermatol; 2008 Aug 30; 159 Suppl 2():18-24. PubMed ID: 18700911
    [Abstract] [Full Text] [Related]

  • 16. Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis.
    Leman J, Burden AD.
    Br J Dermatol; 2012 Nov 30; 167 Suppl 3():12-20. PubMed ID: 23082811
    [Abstract] [Full Text] [Related]

  • 17. Biologic agents in the treatment of psoriasis.
    Guarneri F, Guarneri C, Guarneri B.
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov 30; 1(3):193-217. PubMed ID: 19075983
    [Abstract] [Full Text] [Related]

  • 18. Combining traditional systemic and biologic therapies for psoriasis.
    Heffernan MP.
    Semin Cutan Med Surg; 2010 Mar 30; 29(1):67-9. PubMed ID: 20430311
    [Abstract] [Full Text] [Related]

  • 19. Advancements in the treatment of psoriasis: role of biologic agents.
    Rich SJ, Bello-Quintero CE.
    J Manag Care Pharm; 2004 Mar 30; 10(4):318-25. PubMed ID: 15298530
    [Abstract] [Full Text] [Related]

  • 20. [Use of biologicals in psoriasis].
    Friedrich M, Philipp S, Sabat R, Asadullah K, Sterry W.
    Z Rheumatol; 2003 Oct 30; 62(5):439-49. PubMed ID: 14579031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.